Glibenclamide: proven facts, perspectives, discussions
作者： N I Chepliaeva
DOI: 10.14341/PROBL201359357-62
关键词:
摘要: Despite the discussion about cardiovascular risk glibenclamide has proved its efficacy and safety by 40 years of clinical practice. Basing on numerous experimental publications continued investigations, perspectives glibenclamide's use in treatment traumatic ischemic injuries CNS are presented.
endojournals.ru 参考文章(30)
R F Carlson, W L Isley, T R Klobucar, F G Ogrinc, Efficacy and safety of reformulated, micronized glyburide tablets in patients with non-insulin-dependent diabetes mellitus: a multicenter, double-blind, randomized trial. Clinical Therapeutics. ,vol. 15, pp. 788- 796 ,(1993)
J. Marc Simard, Vladimir Yurovsky, Natalia Tsymbalyuk, Ludmila Melnichenko, Svetlana Ivanova, Volodymyr Gerzanich, Protective Effect of Delayed Treatment With Low-Dose Glibenclamide in Three Models of Ischemic Stroke Stroke. ,vol. 40, pp. 604- 609 ,(2009) , 10.1161/STROKEAHA.108.522409
Mingkui Chen, Yafeng Dong, J. Marc Simard, Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. The Journal of Neuroscience. ,vol. 23, pp. 8568- 8577 ,(2003) , 10.1523/JNEUROSCI.23-24-08568.2003
Mahmoud Loubani, Alan Fowler, Nicholas B. Standen, Manuel Galiñanes, The effect of gliclazide and glibenclamide on preconditioning of the human myocardium. European Journal of Pharmacology. ,vol. 515, pp. 142- 149 ,(2005) , 10.1016/J.EJPHAR.2005.04.002
Kirk N Garratt, Peter A Brady, Nancy L Hassinger, Diane E Grill, Andre Terzic, David R Holmes, Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction Journal of the American College of Cardiology. ,vol. 33, pp. 119- 124 ,(1999) , 10.1016/S0735-1097(98)00557-9
Marc Rendell, The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus Drugs. ,vol. 64, pp. 1339- 1358 ,(2004) , 10.2165/00003495-200464120-00006
JP Riveline, N Danchin, F Ledru, M Varroud-Vial, G Charpentier, Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications Diabetes & Metabolism. ,vol. 29, pp. 207- 222 ,(2003) , 10.1016/S1262-3636(07)70030-7
P. Proks, F. Reimann, N. Green, F. Gribble, F. Ashcroft, Sulfonylurea Stimulation of Insulin Secretion Diabetes. ,vol. 51, ,(2002) , 10.2337/DIABETES.51.2007.S368
Ashish D. Patel, Volodymyr Gerzanich, Zhihua Geng, J. Marc Simard, Glibenclamide Reduces Hippocampal Injury and Preserves Rapid Spatial Learning in a Model of Traumatic Brain Injury Journal of Neuropathology and Experimental Neurology. ,vol. 69, pp. 1177- 1190 ,(2010) , 10.1097/NEN.0B013E3181FBF6D6
Andrey P. Babenko, Gabriela Gonzalez, Joseph Bryan, Two regions of sulfonylurea receptor specify the spontaneous bursting and ATP inhibition of KATP channel isoforms. Journal of Biological Chemistry. ,vol. 274, pp. 11587- 11592 ,(1999) , 10.1074/JBC.274.17.11587